CORRECTION – Visionary Holdings Inc.TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report" on Monday, January 12th by Visionary Holdings Inc. (Nasdaq: GV), please be advised that the headline and content have been updated to accurately reflect comments from the U.S. Securities and Exchange Commission. The corrected release follows:
Visionary Holdings Inc. Reports Fiscal Year 2025 Annual ReportHighlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses
Visionary Holdings Inc. Announces Key Governance Updates, Strategic Pivot to High-End Medical Aesthetics, and Timeline for Annual Report FilingMARKHAM, Ontario, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (the “Company”), today announced several material corporate developments, including the results of its 2025 Annual General Meeting, the formation of a new leadership team, and a formal strategic shift toward the anti-aging high-end medical aesthetics sector. A copy of the company’s Report on Form-6K is being provided as an exhibit to this press release for reference.
Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China MarketHONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited（“GV Hong Kong”）, has official appointed Ms. Wenxuan Cai as Chief Executive Officer of GV Hong Kong, effective immediately.
